Christine Fox, EVP, Head of U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 38,776 shares at $16.87 ($654K) on 2024-11-20, disclosed to the SEC on 2024-11-21.
Scheduled sale ($654k) by EVP, Head of U.S. Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.87 | 19,388 | $327K | 50.0% |
| 2 | $16.87 | 19,388 | $327K | 50.0% |
| Total | $16.87 avg | 38,776 | $654K | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $591K | — | Filing → |
| TEVA | SELL | 2025-11-24 | $1.4M | — | Filing → |
| TEVA | SELL | 2025-11-18 | $753K | — | Filing → |